various signalling pathways including modulation of ion transport. LPA signalling through its receptor LPA 1 is also related to the progression of fibrosis. This study investigated the modulation of lipid signalling pathways induced by administration of bone marrow-derived mononuclear cells (BMMC) in chronic kidney disease. Methods. Unilateral ureteral obstruction (UUO) was followed by intravenous injection of ∼2×10 7 BMMC. Controls were UUO group treated with buffered solution and sham-operated group. Animals were killed 14 days after surgery, and lipid phosphorylation assays and immunoblotting were performed on the kidney homogenates. Results. More DAG was available in the UUO rats (2.4 ± 0.4 and 2.4 ± 0.3 vs 1.0 ± 0.2 pmol 32 PA mg −1 min −1 , in UUO and UUO + BMMC vs SHAM). Sphingosine kinase was 150 ± 12% more active in UUO + BMMC than in UUO and SHAM. Cer levels were 76 ± 7% lower in the UUO + BMMC than UUO. LPA receptor type 1 (LPA 1 ) expression was 169 ± 7% higher in the UUO group than in UUO + BMMC and SHAM. BMMC maintain control levels of Ca 2+ -ATPase expression altered by UUO by 40%. Conclusions. BMMC infusion modulated diverse lipid signalling pathways and protein expression, shifted sphingolipid metabolism toward a regenerative pattern and favourably reduced the levels of a receptor involved in the progression of tissue fibrosis. These results strengthen the benefits of BMMC treatment and give insight into its paracrine mechanisms of action.
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Conclusions. BMMC infusion modulated diverse lipid

Introduction
Since dialysis was brought into the clinic in 1950 during the Korean War, there has been little progress in the treatment of renal failure. Nevertheless, the numbers of acute and chronic renal failure patients have risen substantially worldwide [1] . A new therapeutic approach is necessary when available renal replacement therapy (peritoneal dialysis, haemodialysis, kidney transplantation) does not improve the recovery of kidney function and/or fails to meet increasing needs. During the past decade, several studies have investigated the efficacy of stem cell therapy in different tissues including the kidney. While important questions remain to be answered, some beneficial results have been obtained.
Bone marrow stem cells have been extensively studied. Among these, mesenchymal stem cells (MSC) are mainly associated with the inhibition of apoptosis and fibrogenesis, stimulation of mitosis and immunomodulation [2] , whereas haematopoietic stem cells are reported to be vasculogenic [3] . Unfractionated bone marrow mononuclear cells (BMMC) have also been shown to enhance regeneration and are currently being used to treat humans [4] . Recently, other stem cell sources such as side population cells and inducible pluripotent stem cells have been investigated [5, 6] . So far, the encouraging but controversial results have made it impossible to determine the best stem cell source for each purpose. Another important issue is the mechanism of action of these cells. Differentiation of the stem cell into a specific tissue phenotype, fusion of the stem cell with a differentiated tissue cell, immunomodulation and/or paracrine support to injured differentiated tissue cells or stem cells endogenous to the tissue are among the proposed hypotheses. Although paracrine and endocrine support are considered the most probable mechanisms [7] [8] [9] , the secreted factors responsible for the accomplishments of the stem cells have not yet been identified. Some clues have been provided by investigating the efficacy of MSC in which the expression of specific growth factors has been knocked down with siRNA. These studies have demonstrated that vascular endothelial growth factor (VEGF) [8] and insulin-like growth factor 1 (IGF-1) [10] are important mediators in kidney protection, but it is reasonable to believe that multiple factors act in concert leading to regeneration. Investigation of the signalling routes modulated by cell therapy could help to identify some of these effectors.
Bioactive lipids are an interesting class of mediators that are important either in injury progression or tissue repair. Moreover, dysregulation of the lipid balance is known to contribute to different diseases [11, 12] , and enzymes responsible for lipid metabolism are already being used as pharmacological targets. Recognition that cellular processes are regulated by lipid mediators such as diacylglycerol (DAG), phosphatidic acid (PA), lysophosphatidic acid (LPA) [13] and those from the sphingolipid rheostat [ceramide (Cer), sphingosine and sphingosine-1-phosphate (S1P)] [14] has stimulated great interest in these bioactive lipids. The rationale for examining these specific signalling lipids in the present study relies on their role in key steps during lesion/repair processes in different tissues. DAG is associated with phospholipase C activation during injury [15, 16] among other processes [17] , LPA and its receptors are specially associated to the progress of fibrosis [18, 19] and free Cer is released after activation of sphingomyelinase [20, 21] . In contrast, formation of S1P is associated with cell survival and proliferation [22] .
In a recent study [23] , we described the beneficial effects of BMMC in the evolution of inflammatory and fibrotic cellular markers in chronic kidney disease (CKD) induced by unilateral ureteral obstruction (UUO). This model of kidney injury is characterized by progressive loss of renal tubules and a sustained inflammatory and fibrogenic response [24] . The purpose of this investigation was to evaluate whether the actions of BMMC involve the above mentioned lipids. Expression of Ca 2+ -ATPase, a key iontransporting protein in plasma membranes, was also investigated. This transporter is considered a fine tuner of cytosolic Ca 2+ and a modulator of signalling Ca 2+ transduction [25] .
Materials and methods
Materials
Buffers and protease inhibitors were obtained from Sigma Chemical Co. (Saint Louis, MO). Distilled water, deionized using the Milli-Q system of resins (Millipore Corp., Marlborough, MA), was used to prepare all solutions. 32 P i was obtained from IPEN (São Paulo, Brazil). [γ-32 P]ATP was prepared as described by [26] . All other reagents were of the highest purity available. The antibody against LPA receptor type 1 (EDG2) was from Sigma-Aldrich (St. Louis, USA). The antibody 5F10 against plasma membrane Ca 2+ -ATPase was purchased from Sigma-Aldrich. Thin layer chromatography (TLC) plates and solvents for chromatography were from Merck (Darmstaadt, Germany). X-Omat™ diagnostic film was from Eastman Kodak Co. (Resende, Brazil).
Animals
Male adult Wistar rats were obtained and housed under controlled temperature conditions (23°C) with daily exposure to a 12:12 h light-dark cycle. The well-defined UUO animal model for chronic renal disease was used as previously described [23, 27] . The animals were divided into three experimental groups: sham-operated controls, UUO and UUO treated with BMMC. The rats were euthanized 14 days after UUO. All the animal procedures were performed according The Guide for Care and Use of La Isolation of BMMC BMMC were obtained from the femurs and tibias of isogenic donor Wistar rats in a routine protocol, as already described [28] . Briefly, femurs and tibias were harvested and thoroughly cleaned of all muscle tissue. Bone marrow was flushed using Dulbecco's Modified Eagle Medium (GibcoInvitrogen, Carlsbad, CA, USA), and the resultant cell suspension was centrifuged (400 g for 30 min) in a Ficoll gradient (Histopaque 1083, 1:1, Sigma-Aldrich). BMMC were collected from the Histopaque medium interface and were washed twice with buffered saline solution (BSS) prior to cell counting. Trypan blue was used to check cell viability after this procedure.
Injection of BMMC into UUO rats
BMMC (2 × 10 7 ), diluted in 1 mL of BSS, were injected into the inferior vena cava of each obstructed rat in the treated group (UUO + BMMC) immediately after the obstruction procedure. The UUO and SHAM groups received 1 mL BSS through the same vein.
Rat and kidney weights
Rats were weighed prior to being killed and the kidneys were removed and weighted. The renal index was calculated as the ratio of kidney wet weight to total body weight.
Homogenization of kidney cortex
Kidney cortex homogenate was obtained using a previously described method with a few modifications [29] . Briefly, the kidneys were removed immediately after the animal's death and maintained in an ice-cold solution containing (millimolar): 250 sucrose, 10 Hepes-Tris (pH 7.6), 2 EDTA, 1 phenylmethanesulfonyl fluoride, supplemented with 0.15 mg/ mL soybean trypsin inhibitor. The external portion of the cortex (cortex corticis), enriched in proximal tubules, was carefully removed with a Stadie Riggs microtome. After dissection, slices were homogenized in the same cold solution with a Teflon and glass homogenizer. The homogenate was centrifuged for 15 min at 2000 g in a SCR20B centrifuge using an RP12-2 rotor at 4°C. The supernatant was collected and stored at −4°C.
Protein determination
A 10-µL aliquot (in triplicate) was used for protein assays, which were performed by the Folin phenol method described by Lowry et al. [30] with 5% SDS added to the samples. Bovine serum albumin was used as standard.
Lipid analysis by TLC After incubation of the homogenate with [γ-32 P]ATP, total lipids were extracted by adding 5 mL chloroform:methanol:HCl (2:1:0.075, v/v) as described by Horwitz and Perlman [31] . The lipids were separated and first identified by TLC, using chloroform:acetone:methanol:acetic acid:water (120:45:39:36:24, v/v). Lipids phosphorylated by [γ-32 P]ATP by lipid kinases in the preparation were detected by exposing the TLC plates overnight to a phosphor screen and analysed using a PhosphorImager Storm 860 (Molecular Dynamics, Amersham Pharmacia Biotech., Sunnyvale, CA). This method was applied to the studies of S1P and PA generation.
Cer-1-phosphate and LPA
To quantify the endogenous level of Cer by phosphorylation to Cer-1-phosphate (C1P) and LPA formation, the homogenate was incubated with [γ-
32 P]ATP. Total lipids were extracted, as previously described [32] , by adding 8.6 mL chloroform/methanol (1:1 v/v) and 3.6 mL MOPS-KCl (1 M). The lipids were separated and identified by TLC as described above.
SDS-PAGE and immunoblotting
Kidney homogenate proteins derived from the three experimental groups were separated by electrophoresis, followed by immunodetection of (i) the LPA 1 receptor with the EDG2 antibody or (ii) the plasma membrane Ca 2+ -ATPase with 5F10 antibody. A 12% polyacrylamide gel was used and immunoblotting was as previously published by our group [33, 34] .
Statistical analysis
The means were compared by two-way ANOVA, taking the treatment of the experimental groups into account. The differences were evaluated using the multiple comparative Bonferroni test. In all cases, the n values correspond to the number of preparations examined from the three experimental groups, which comprised at least three rats each.
Results
BMMC attenuate renal damage
The left obstructed kidney was greatly enlarged after 14 days of UUO ( Figure 1A-B) owing to urine accumulation and expansion of the interstitial space by collagen deposition [23] . Bisection of the kidneys showed that the renal medulla was ablated and the cortex thinned ( Figure 1C) . Treatment of the rats with an intravenous BMMC infusion resulted in less enlargement of the obstructed kidneys ( Figure 1D) , as confirmed by quantification of the renal mass and evaluation of the renal index (kidney mass/body mass) (Figure 2 ).
Blood urea nitrogen and serum creatinine did not differ among the groups (data not shown), indicating that the contralateral (unobstructed) kidney sufficed for normal excretion. Analysis of the urine collected in metabolic cages reveals that excretion of water, Na + , K + , creatinine and urea does not differ among the three experimental groups (A. L. Barreira, personal communication). The morphological and structural benefits of BMMC treatment in this model of CKD were recently demonstrated by our group [23] .
BMMC shift the sphingolipid profile
To evaluate the important lipid mediators associated with cellular apoptosis, we first measured sphingosine kinase (SK) activity and endogenous Cer content. SK phosphorylates sphingosine (Sph), a pro-apoptotic lipid, converting it to S1P, an anti-apoptotic lipid involved in proliferation, among other cellular processes. When exogenous Sph was added to the phosphorylation assay, more S1P was formed in the UUO + BMMC group than in the UUO alone and control groups (Figure 3 ). This could be attributed to either elevated SK activity or increased expression.
The level of Cer, another sphingolipid associated with cell death, was evaluated by quantifying the formation of C1P by Cer kinase [32] . Figure 4 shows that UUO increased the Cer content of the obstructed kidney, and that BMMC treatment maintained the normal Cer levels seen in the left kidney of SHAM and in the contralateral kidneys from the experimental groups. These latter two results are complementary and indicate a shift from a predominantly apoptotic lipid profile in UUO to an anti-apoptotic one induced by BMMC infusion.
BMMC do not alter the glycerolipid balance
Among the signalling glycerolipids, we investigated the formation of PA and LPA. PA is the product of diacylglycerol kinase (DGK) phosphorylation of free DAG, an important lipid mediator that acts as second messenger in various signalling pathways [17] . In contrast, LPA results from the action of phospholipases (PLA and PLD). LPA signalling through different receptors has already been associated with cell survival, proliferation, migration, de-differentiation and more recently with fibrogenesis [17, 18, 35] .
UUO induced a significant increase in PA levels, and although BMMC infusion did not alter this pattern ( Figure 5) , it is important to note that the intense tissue activities in both groups (UUO and UUO + BMMC) may be subdued by the progression of injury and/or by repair attempts. Investigation of LPA metabolism showed no differences among the groups studied ( Figure 6 ).
BMMC maintain LPA 1 receptor at control levels
We further investigated the LPA signalling pathway by evaluating the expression of LPA 1 R (LPA type 1 receptor), which was recently reported to be directly responsible for fibrosis in this model of injury [18] . Quantification of the bands representing the monomeric form of LPA 1 showed no difference among groups (Figure 7) . Interestingly, the UUO group gave a second band, of higher molecular weight (∼90 kDa), indicating the formation of dimers. BMMC treatment prevented the appearance of this second band, maintaining LPA 1 R at control levels.
BMMC preserve normal plasma membrane Ca 2+ -ATPase expression
Since cytosolic Ca 2+ is a key modulator of several cell functions and the plasma membrane Ca 2+ -ATPase is responsible for the fine regulation of intracellular Ca 2+ levels [25] , we investigated whether obstruction and BMMC infusion would modify the expression of this ion pump. Figure 8 shows that the UUO group has a decreased Ca 2+ -ATPase 
Discussion
Bioactive lipids such as those studied in the present work are an emerging class of mediators that play crucial roles in both lesion progression and tissue repair. Nonetheless, their possible contribution to different cell therapy protocols is still overlooked.
It is well known that stress responses are associated with increased intracellular levels of free Cer [20, 21, 36] . Activation of sphingomyelinases and the de novo synthesis of the Cer pathway have already been reported to contribute to Cer accumulation in different stress situations [21, 37] . Among the several growth-inhibiting effects of Cer (differentiation, cell cycle arrest, senescence), apoptosis is the most studied and prominent outcome. Although the exact mechanism of Cer signalling remains to be deciphered, its involvement in programmed cell death is well established, since the incidence of apoptotic cells in different tissues and cell types correlates strongly with the rise in Cer content [38] . In the present work, the Cer level was increased in the UUO group, and BMMC treatment blunted this effect (Figure 4 ). These data correlate well with our previous results, in which the number of apoptotic cells was hugely increased in UUO but returned to low levels in the UUO + BMMC group [23] .
BMMC infusion also stimulated SK activity, thus favouring S1P formation (Figure 3) . S1P, in contrast to Cer, promotes proliferation and reduces apoptosis [22] . mod, a potent agonist of S1P receptors, protects renal epithelium during severe injury [39] . The increased levels of S1P, found in the present study, may partially explain the histopathological benefits of BMMC administration recently demonstrated by our group: decreased macrophage infiltration, increased tubule cell proliferation and decreased apoptosis [23] . SK activity is reportedly stimulated by VEGF in endothelial cells [40] , and S1P is considered to mediate the proliferative effect of VEGF. The role of VEGF in kidney repair when MSC are administered [8] adds support to the view that its mediator S1P plays an important part in tubular regeneration.
Glycerolipids are involved in different signalling pathways including modulation of transepithelial transport [41, 42] . Phospholipases are known to be involved in cell membrane remodelling during injury/repair processes. An intense phospholipase activity leads to massive generation of DAG, which stimulates different protein kinases of the C family (PKC) involved in cell processes such as migration, proliferation, apoptosis and differentiation [17, 43] . We observed that UUO induced an increase in DAG availability and that BMMC infusion did not prevent this effect ( Figure 5 ). Nevertheless, we note that different PLCs and PKCs lead to multiple signalling pathways and have opposing effects. Thus, although the similar increased levels of free DAG indicate intense signalling activities in both groups (UUO and UUO + BMMC), they might be attained by divergent routes triggered in each case. Injury, remodelling and repair in a myriad of pathological processes are accompanied by PLC activation and, therefore, by increased release and tissue levels of DAG [17, 44] .
The combined results of Figures 6 and 7 support the above hypothesis. Although the levels of renal LPA are the same after 14-day obstruction (Figure 6 ), it is plausible that it triggers different signalling cascades because expression of the LPA 1 receptor is augmented in UUO and normalized after BMMC treatment (Figure 7) . LPA receptors are known to be modulated by renal injury, which causes downregulation (LPA 3 receptor) or overexpression (LPA 1 receptor). In both kidney [18] and lung [19] , LPA 1 receptors appear to be directly involved in tissue fibrosis. The observed dimerization of LPA 1 , favoured by its overexpression, might be an important step toward the evolution of tubulointerstitial fibrosis in CKD. In human embryonic kidney cells, Zaslavsky and coworkers [45] demonstrated homo-and heterodimerization of LPA receptors in vitro as the result of their overexpression. To our knowledge, this is the first report showing formation of LPA 1 receptor dimers in vivo and their dissociation by BMMC.
The influence of BMMC in signalling events during the repair of lesions after UUO extends beyond the modifications above described. It is also exerted on a key protein in tubule cells: the Ca 2+ -ATPase resident in the basolateral membranes. This pump, of which expression is severely decreased in UUO, is preserved if BMMC are infused (Figure 8) . Interestingly, the opposite alterations found in the contralateral kidney can be ascribed to a compensatory attempt to maintain cytosolic Ca 2+ levels challenged by the extra-work required to preserve the normal water and solutes handling, above mentioned.
Conclusion
In conclusion, we demonstrate that although the chronic UUO lesion persists, there is a trend towards tissue recovery in the BMMC-treated group. In a previous work with the use of this model [23] , we showed that BMMC infusion reduced ED1 + cells, myofibroblasts, apoptotic cells and collagen deposition and enhanced tubular proliferation. Here we demonstrate that these beneficial influences of BMMC are associated with a shift in the bioactive lipids from a pattern characteristic of the lesion to one indicating repair.
